It’s easy to forget that generative AI launched into the economy—and the public imagination—less than two years ago. How could it be otherwise?

Researchers tracked the long-term safety, effectiveness and durability of first-generation CoreValve devices in nearly 900 patients.

This sort of tool could be a game changer for prenatal care in low resource settings, authors of a new paper published in JAMA suggest. 

The new medical device correction only includes a select number of devices. Abbott said they produce inaccurate readings, putting patient health at risk. 

Colorado University physicians believe the facility is vital, given a growing number of patients diagnosed with chronic renal disease. 

Buzzworthy developments of the past few days. 1. The Federal Trade Commission isn’t messing around.

Patient safety should be the No. 1 consideration for healthcare organizations working, planning or hoping to adopt AI. Then again, nine other concerns are similarly crucial to the success of the industry-wide endeavor.

Individuals are 83% more likely to be diagnosed with a psychiatric disorder within one year of a CVD hospitalization, according to new data published in the Journal of the American Heart Association.